A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges

Diabetes Technology& Therapeutics , Vol. 0, No. 0.

Source: Diabetes Technology - March 9, 2017 Category: Endocrinology Source Type: research